0074-3799 NDC - HUMIRA (ADALIMUMAB)

Drug Information

Product NDC: 0074-3799

Proprietary Name: Humira

Non Proprietary Name: Adalimumab

Active Ingredient(s):


Administration Route(s):

Dosage Form(s): KIT

Labeler Information

Labeler Name: AbbVie Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125057
Marketing Category: BLA
Start Marketing Date:12/31/2002

Package Information

No. Package Code Package Description Billing Unit
10074-3799-022 KIT in 1 CARTON (0074-3799-02) > 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY > .8 mL in 1 SYRINGE * 1 mL in 1 PACKETEA
20074-3799-033 KIT in 1 CARTON (0074-3799-03) > 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY > .8 mL in 1 SYRINGE * 1 mL in 1 PACKETEA
30074-3799-066 KIT in 1 CARTON (0074-3799-06) > 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY > .8 mL in 1 SYRINGE * 1 mL in 1 PACKETEA
40074-3799-712 KIT in 1 CARTON (0074-3799-71) > 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY > .8 mL in 1 SYRINGE * 1 mL in 1 PACKET

NDC Record

Field Name Field Value Definition
PRODUCT NDC0074-3799The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEHumiraThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAdalimumabThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEKITThe translation of the dosage form Code submitted by the firm.
START MARKETING DATE12/31/2002This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEBLAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERBLA125057This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEAbbVie Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 8/16/2019